David Sourdive
Company: Cellectis Stem Cells
Job title: Co-Founder & Executive Vice President, CMC & Manufacturing
Seminars:
Highlighting the First Generation of CAR-T Therapies & Outlining the Future Direction 9:00 am
Lessons learned from the first generation of CAR-Ts and how they are changing cell therapy Broadening the spectrum of indications addressable with CAR-T The next step: unlocking the full power of cell therapies by engineering biological scenarios with genomic design of smart cellsRead more
day: Cell Therapy Fundamentals Day